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Abstract
Background: In opioid maintenance treatment (OMT) there are documented treatment differences both between 
countries and between OMT programmes. Some of these differences have been associated with staff attitudes. The 
aim of this study was to 1) assess if there were differences in staff attitudes within a national OMT programme, and 2) 
investigate the associations of staff attitudes with treatment organisation, clinical practices and outcomes.
Methods: This study was a cross-sectional multicentre study. Norwegian OMT staff (n = 140) were invited to participate 
in this study in 2007 using an instrument measuring attitudes towards OMT. The OMT programme comprised 14 
regional centres. Data describing treatment organisation, clinical practices and patient outcomes in these centres were 
extracted from the annual OMT programme assessment 2007. Centres were divided into three groups based upon 
mean attitudinal scores and labelled; "rehabilitation-oriented", "harm reduction-oriented" and "intermediate" centres.
Results: All invited staff (n = 140) participated. Staff attitudes differed between the centres. "Rehabilitation-oriented" 
centres had smaller caseloads, more frequent urine drug screening and increased case management (interdisciplinary 
meetings). In addition these centres had less drug use and more social rehabilitation among their patients in terms of 
long-term living arrangements, unemployment, and social security benefits as main income. "Intermediate" centres 
had the lowest treatment termination rate.
Conclusions: This study identified marked variations in staff attitudes between the regional centres within a national 
OMT programme. These variations were associated with measurable differences in caseload, intensity of case 
management and patient outcomes.
Background
Opioid maintenance treatment (OMT) is recognised as
an effective treatment in opiate dependence [1-3]. How-
ever OMT is a contentious issue and there are many
views on how to organise this treatment [4,5]. OMT pro-
grammes differ in treatment objectives, organisation and
clinical practices [6,7]. Treatment objectives range from
harm reduction [8], long-term maintenance and rehabili-
tation [2], to abstinence from all drugs including treat-
ment medication [9]. Diversity in treatment is evident
between countries [10], within countries [11], and even
between counsellors within the same treatment pro-
gramme [12]. Such differences have been associated with
variations in programme policies and staff attitudes [13-
15].
Several studies have assessed staff attitudes in the
addiction field [16-19]. Differences in staff attitudes have
been associated with treatment practices and outcomes
[20-22]. OMT staff 's favour towards abstinence-models
has been associated with provision of low dose metha-
done [22,23]. Abstinence-oriented OMT staff have had
more in-treatment drug use and more drop out com-
pared to programmes where staff were long-term mainte-
nance-oriented [20,21,24]. Strong attitudes and the
beliefs of the majority are more likely to influence behav-
iour than weaker attitudes held by only one or few per-
sons [25-28]. Consequently staff attitudes should be
included when OMT programmes are assessed.
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Page 2 of 8There are between 8 200 and 12 000 injecting drug
users in Norway [29] and approximately 5000 are cur-
rently in OMT [30]. In Norway OMT is only available
through a single publicly funded programme [31]. The
programme was established in 1998 and it has had a rapid
expansion from the initial intake of 240 patients to 4542
patients in 2007 [30]. The programme comprises 14
regional centres that are subject to the same treatment
standards specified in government guidelines [31].
Annual assessments of the OMT programme indicate
marked differences in treatment organisation, practices
and outcomes between centres [32,33]. This is of concern
since not all centres appear to achieve outcomes in line
with specified programme aims; reduced drug use and
improved social rehabilitation. Also OMT in Norway
relies on long-term three-party collaboration between an
OMT centre, a GP and social services, thus patients are
not entirely free to choose their treatment centre due to
logistical and geographical challenges. This means that
patients are required to accept their local centre's treat-
ment standards and practices. Thus it is important to
investigate factors that may be associated with differences
in treatment delivery and outcomes. The aim of this study
was to 1) assess if there were differences in staff attitudes
between OMT centres, and 2) investigate the associations
of staff attitudes with treatment organisation, clinical
practices and outcomes.
Methods
Setting
All clinical OMT staff (n = 140) in full-time and part-time
positions, in the national OMT programme in Norway
were invited to participate in this study. A list of all clini-
cal staff at each centre ensured that all staff were invited.
The national OMT programme comprised of fourteen
centres, and had from three to thirty-three staff
employed. In this study two of the fourteen centres were
merged because they had a joint staff group at the time of
the study.
Design
The study was a cross-sectional multicentre study. Data
was collected from August to November 2007, through
visits by the first author. The visits were in conjunction
with staff meetings when most staff were present. Staff
that were absent returned the questionnaire by mail. The
first author was present during the completion of the
questionnaires in all except one OMT centre. In the latter
OMT centre the researcher gave information during a
staff meeting and thereafter questionnaires were
returned by mail. Prepaid and anonymous envelopes
addressed to the researcher were attached to each ques-
tionnaire. Responders could choose not to respond to the
survey by returning an incomplete questionnaire in the
envelope. No names were collected, but number of staff
that had completed the questionnaire at each facility was
recorded. Centre managers were followed up to encour-
age that all staff returned questionnaires.
The study was approved by the Norwegian Regional
Ethics Committee and the Data Inspectorate May-June
2007. Participants received written and oral information
about the study. Respondents consented to participate in
the study by submitting the questionnaire. The question-
naire was semi-anonymous. This means that the name of
the facility and other demographic variables made some
staff theoretically identifiable. Participants were prom-
ised full anonymity. Demographic variables that identify
respondents will therefore be deleted upon completion of
the project.
Study instrument
The study instrument included a 13-item attitudinal scale
(Table 1). This scale was developed through exploratory
factor analysis and confirmed in structural equation
modelling using maximum likelihood analysis [34]. The
scale comprised two factors; "compliance" and "accessi-
bility" that were highly correlated in this OMT sample (r
= 0.71) [34]. The "Compliance"-items measured attitudes
towards in-treatment drug use in OMT and the "accessi-
bility"-items measured attitudes towards who should
have access to an OMT programme. The development of
the scale is described in details elsewhere [34]. Partici-
pants were asked to rate their responses to each item on a
five-point Likert scale from strongly disagree = 1 to
strongly agree = 5. Total scores were divided by number
of questions answered [35]. The theoretical range of
mean scores was 1.00 to 5.00.
Demographic variables such as treatment centre, age,
gender, profession, time employed in the organisation
and time worked in the addiction field were collected.
Labelling
In this study it was decided to label those with the lowest
mean scores on the attitudinal scale "harm reduction-ori-
ented" and those with the highest mean scores "rehabili-
tation-oriented". These labels were based upon the
content of the attitudinal scale. This means that the
"harm reduction-oriented" would be more likely to dis-
agree that drug use was a reason for disciplinary dis-
charge, more likely to agree that an OMT programme
should be available to all opiate dependents and more
likely to agree that GPs should be able to treat OMT
patients independently of the OMT programme. "Reha-
bilitation-oriented" would have opposite attitudes.
Division of centres into attitudinal groups
Each centre's mean attitudinal score was assessed. Cen-
tres were divided into three groups based upon these
scores, with equal number of centres in each group (4-5-
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Page 3 of 84). The four centres with the lowest scores were termed
"harm reduction-oriented" and the four centres with the
highest scores were termed "rehabilitation-oriented". The
five centres that had attitudinal scores between the two
opposing groups were termed "intermediate" centres.
OMT centre characteristics
The Norwegian OMT programme is assessed annually as
part of an ongoing quality assessment. A 53-item ques-
tionnaire is to be completed for each OMT patient. The
questionnaire comprises items such as main income,
employment status and drug use previous four weeks.
The questionnaire is completed by the patients' case
manager. The questionnaire was reliability tested in 2005
[36] and revised according to findings. Data was collected
as a multicentre study; however only aggregated informa-
tion was available for analysis. This study used data col-
lected in the third quarter of 2007.
Treatment variables and treatment outcomes
Patient/staff ratio, methadone and buprenorphine dose,
and interdisciplinary meeting attendance among patients
as well as supervised dispensing and urine drug screening
at each OMT centre were selected as treatment variables.
Drug use and social functioning variables were outcome
variables. Drug use variables were opioid, benzodiaz-
epines, central stimulants and cannabis use previous four
weeks. These data were measured by urine testing and
self-report. Social functioning was measured using cur-
rent employment status, social security benefits as main
income and type of living arrangements. Patient retention
was measured indirectly using the treatment termination
rate. This rate was calculated by adding all patients at the
beginning of the year to all new patients throughout the
year (n1). Thereafter this (n1) was subtracted from the
total number of patients at the end of the year (n2). Finally
this (n1-n2) was divided by the sum of all patients at the
beginning of the year and all new patients throughout the
year (n1).
Data analysis
Descriptive statistics and regression analysis were com-
pleted using SPSS version 16.0 [37]. A missing value pat-
Table 1: The 13-item scale measuring attitudes towards opioid maintenance treatment*
1 OMT patients who ignore repeated warnings to stop using heroin should be gradually withdrawn off methadone
2 OMT patients who continue to abuse non-opioid drugs (e.g. benzodiazepines) should have their dose of OMT medication reduced.
3 If repeated warnings of non-prescriptive use of benzodiazepines are ignored, the patient should be discharged from the OMT 
programme
4 If repeated warnings of use of Cannabis are ignored, the patient should be discharged from treatment (OMT)
5 The GP should waive the right to prescribe class A and B drugs other than the OMT medication to OMT patients
6 OMT patients who continue to take drugs and function poorly should be discharged from the OMT programme
7 It is unethical to discharge patients from the OMT programme due to continuing drug use and poor functioning**
8 OMT services should be expanded so all heroin addicts who want OMT can receive it**
9 It is unethical to deny heroin addicts OMT**
10 OMT's main aim is to reduce harmful effects of opioids and IV drug use (syringes)**
11 GPs should be able to initiate OMT on their own initiative**
12 Too many OMT-patients are discharged from the OMT programme**
13 Young opioid dependents (< 20) should not be offered OMT
*Participants were asked to rate their responses to each item on a five-point Likert scale from strongly disagree = 1 to strongly agree = 5.
** Reversed scores
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investigated by linear regression analysis with mean atti-
tudinal score as dependent variable and age, gender, staff
category, years of education, time worked in the addic-
tion field and OMT centre as independent or predictor
variables. Prevalence estimates were reported [38]. Dif-
ferences between centres were calculated using preva-
lence difference and 95% CI. Data on centre
characteristics were only available as aggregated informa-
tion (number of patients for each variable and total num-
ber of patients) for each regional centre (14 centres) was
available for analysis. Only completed items, from the
annual OMT assessment, were included in the analysis.
Not all items in each patient questionnaire were com-
pleted, thus the total number of respondents for each
item varied from the total number of patients at each cen-
tre.
Results
Respondents
All invited staff (n = 140) responded. One questionnaire
(1%) was discarded due to incomplete answers. Two
questionnaires had two missing responses and five ques-
tionnaires had one missing response, all items were com-
pleted in the remaining questionnaires. There were no
observed differences in age, gender, occupation and
length of employment in the addiction field between
OMT centres. 63% of staff were women. 59% of staff were
either social workers or registered nurses, and 21% were
psychologists and doctors. Other staff categories were
teachers and social educators. The majority of staff (60%)
were between forty and fifty-nine years old. No staff were
below twenty-five years. 62% had worked in the addiction
field more than six years.
OMT centres and staff attitudes
OMT centre was the only independent variable that was
associated with staff attitudes (r = 0.44, b = 0.06 95% CI
0.04; 0.08). No other personal descriptors contributed to
explaining variations in staff attitudes. An assessment of
each OMT centre found that mean attitudinal scores var-
ied from 2.50 (95% CI 2.01; 2.99) to 4.26 (95% 4.02; 4.51).
Treatment practices and staff attitudes
There were 4542 patients in the OMT programme by the
end of 2007. The four centres with the lowest attitudinal
scores ("harm reduction-oriented") comprised 1980
patients. The four centres with the highest attitudinal
scores ("rehabilitation-oriented") comprised 1049
patients (Table 2). Centres between the two opposing
groups in attitudinal scores ("intermediate") comprised
1513 patients. The patient/staff ratio varied between
groups. The "harm reduction-oriented" centres had a
much higher patient/staff ratio (30% (95% CI 27%; 34%, p
> 0.001) than the "rehabilitation-oriented" centres (Table
2).
All three groups had a high dose policy. The median
methadone dose varied from 106-111 mg and buprenor-
phine from 17-20 mg between groups (Table 2). Number
of supervised dispensing per patient per week, i.e. the use
of "take-home doses" did not differ greatly between
groups. However "harm reduction-oriented" centres were
12% (95% CI 5%; 18%, p > 0.001) less likely to collect
weekly urine specimens than the "rehabilitation-ori-
ented". In addition there were differences in number of
patients attending interdisciplinary meetings. 13% less
patients (95% CI 8%; 19%, p > 0.001) attended interdisci-
plinary meetings the previous four weeks in the "harm
reduction-oriented" centres compared to the "rehabilita-
tion-oriented".
The "intermediate" centres had rates in treatment char-
acteristics and practices between the "harm reduction-
oriented" and "rehabilitation-oriented" in most variables
(Table 2).
Treatment outcomes and staff attitudes
"Harm reduction-oriented" centres had more in-treat-
ment drug use compared to the two other groups (Table
3). More than half of the patients (55%) had used benzo-
diazepines previous four weeks compared to 32% in
"rehabilitation-oriented" centres. Furthermore "harm
reduction-oriented" centres had less social functioning
among their patients compared to the "rehabilitation-ori-
ented" centres; 17% more patients were unemployed, 12%
more patients had social security benefits as main income
and 15% less patients had long-term living arrangements
(Table 3). The "intermediate" centres were between the
"harm reduction-oriented" and "rehabilitation-oriented"
centres in all treatment outcomes. The exception was the
treatment termination rate, where the "intermediate" cen-
tres had the lowest rate.
Discussion
Within one national OMT programme there were differ-
ences between the regional centres in staff attitudes and
these differences were associated with variations in treat-
ment organisation, clinical practices and outcomes. Staff
in "rehabilitation-oriented" centres were more likely to
agree that drug use was a reason for disciplinary dis-
charge, disagree that an OMT programme should be
available to all opiate dependents and less likely to agree
that GPs should be able to treat OMT patients indepen-
dently of the national OMT programme. "Rehabilitation-
oriented" centres had smaller caseloads, more frequent
urine drug screening and increased case management
(interdisciplinary meetings). In addition these centres
had less drug use and more social rehabilitation among
their patients in terms of long-term living arrangements,
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income. "Intermediate" centres had the lowest treatment
termination rate.
Treatment approach has been associated with staff atti-
tudes [13]. Abstinence-oriented staff have provided lower
methadone doses compared to long-term maintenance
oriented staff [20-22]. Staff in pharmacies with negative
attitudes towards drug users have been less likely to pro-
vide needle exchange services [39]. Psychiatric staff with
positive attitudes towards seclusion of patients have been
more likely to be involved in this treatment practice [40].
In the current study centres with "rehabilitation-oriented"
staff urine drug screened more frequently and had
increased case management (interdisciplinary meeting
attendance) of their patients.
"Harm reduction-oriented" centres had almost double
caseload compared to the "rehabilitation-oriented" cen-
tres. Staff in these centres were more likely to agree that
OMT programmes should be open to all opiate depen-
dents and possibly attempted to admit all those who pre-
sented for treatment. Conversely it is possible that staff in
"rehabilitation-oriented" centres emphasised provision of
services and limited their intake to ensure a manageable
caseload.
Caseload affects services provided [41,42]. Smaller
caseloads allow staff more time per patient and this affect
the services provided [41-43]. However small caseloads
are not sufficient to ensure beneficial treatment out-
comes; quality of services, such as case management, are
also important [2]. Several studies have demonstrated
that increased case management are associated with less
drug use and increased social rehabilitation [44,45]. The
"rehabilitation-oriented" centres had smaller caseloads
and more intense case management of their patients.
This is possibly one of the reasons why they had less drug
use and more social rehabilitation among their patients
compared to the "harm reduction-oriented" centres.
Staff disapproval of in-treatment drug use could be
another reason why "rehabilitation-oriented" centres had
less drug use and more social rehabilitation among their
patients. High expectations of functioning have been
found to enhance patients' engagement in treatment ser-
vices and subsequently treatment outcomes [43]. Staff in
"rehabilitation-oriented" centres were more likely to
agree that in-treatment drug use was a reason for dis-
charge from treatment. It is possible that patients were
motivated to abstain from drug use because staff disap-
proved of in-treatment drug use, and thus staff attitudes
influenced patient's outcomes positively.
It is also possible that the "rehabilitation-oriented" cen-
tres only included patients that were less severely affected
and with a higher level of social functioning. A differen-
tial selection of patients into treatment would possibly
influence level of drug use and social functioning of
patients in treatment. Baseline information on each
patient was not available. However there was no differ-
ence between centres in patients' age and gender distribu-
tion. In addition the government regulations of the OMT
programme specify that only those with long-term opioid
dependence should be accepted into treatment. It is
Table 2: Treatment characteristics and practices for OMT centres when divided into attitudinal groups
Characteristics for each group "Harm reduction-oriented" 
centres
"Intermediate" 
centres
"Rehabilitation-oriented" 
centres
Total number of patients per group 1980 1513 1049
Patient/staff ratio 64 50 34
Methadone dose (mg)* 111 mg 111 mg 106 mg
Buprenorphine dose (mg)* 18 mg 17 mg 20 mg
Number of supervised dispensing per patient per week* 4.1 3.9 3.7
Number of patients urine drug screened at least once a week *† 62% (1419) 73% (1325) 74% (1115)
Interdisciplinary meeting previous 4 weeks*† 46% (1493) 49% (1326) 59% (1070)
*Median
† Number of patients in brackets
†† Not all items in each patient questionnaire were completed, thus the total number of respondents for each item varied from the total number 
of patients at each centre.
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i.e. severity of dependence and drug use patterns, could
explain all the observed variations in social rehabilitation
and drug use.
Drug use is an important measure in OMT. Especially
benzodiazepine use has been related to increased risk of
overdose, other drug use, sharing injecting equipment,
and more psychopathology and social dysfunction [46-
48]. The "rehabilitation-oriented" centres had less drug
use and higher rates of social rehabilitation among their
patients.
Retention in treatment is another important treatment
indicator as OMT protect patients against increased risk
of mortality [49]. All centres had low treatment termina-
tion rates, but the "intermediate" centres had the lowest.
It may be that too strong attitudes ("harm reduction-ori-
ented" or "rehabilitation-oriented") in either directions
influence termination rates in OMT negatively.
Overall the cross-sectional design prevented any infer-
ence as to causality. Differences in treatment outcomes
were not necessarily caused by differences in either staff
attitudes or centre policies. Aggregated information pre-
vented detailed analysis based upon individual patients.
In addition the disciplinary discharge of patients for con-
tinuing drug use would reduce the proportion of patients
using drugs while in treatment. There were no systematic
patterns between response rate and treatment practices
and outcomes, which suggested that selection bias was
not a major concern.
Despite these limitations, the present study provides a
detailed description of the Norwegian OMT programme
and differences in staff attitudes, centres and patient out-
comes. This study was able to identify significant differ-
ences in staff attitudes, treatment practices and outcomes
between OMT centres. Furthermore all eligible staff par-
ticipated in this study which support the validity of the
Table 3: Treatment outcomes for OMT centres when divided into attitudinal groups
Treatment outcomes for 
each group
"Harm reduction-oriented" 
centres
"Intermediate" 
centres
"Rehabilitation-oriented" 
centres
Prevalence 
difference* (95% CI)
p-value**
Opioids use previous 
4 week
18% (1260)†† 15% (1215) 14% (1092) 4% (1%; 7%) 0.022
Central stimulant drug use 
previous 4 week
19% (1227) 19% (1200) 16% (1093) 3% (-1%; 6%) 0.102
Benzodiazepine use 
previous 4 weeks
55% (1296) 50% (1229) 32% (1102) 23% (18%; 29%) < 0.001
Cannabis use previous 
4 weeks
46% (1258) 41% (1224) 21% (1090) 25% (20%; 29%) < 0.001
Unemployed in treatment 83% (1503) 77% (1342) 66% (1112) 17% (10%; 23%) < 0.001
Social security benefits as 
main income
24% (1494) 15% (1257) 12% (1111) 12% (9%; 15%) < 0.001
Long-term living 
arrangements for patients 
in treatment
71% (1503) 82% (1344) 86% (1116) -15% (-21%; -8%) < 0.001
Treatment termination 
rate
11% (2213) 9%† (1667) 15% (1241) - 4% (-8%; - 2%) < 0.001
Total number of patients (n) per item in brackets
*Prevalence difference in percent. It was calculated by subtracting the prevalence of "harm reduction-oriented" centres from the prevalence of 
the "rehabilitation-oriented" centres.
**P-values estimated for prevalence difference
† Prevalence difference ("rehabilitation-oriented" vs. "intermediate" centres) 5% (4%; 9%), p-value < 0.001)
††Not all items in each patient questionnaire were completed, thus the total number of respondents for each item varied from the total number 
of patients at each centre.
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responded.
Conclusions
This study identified marked variations in staff attitudes
between the regional centres within one national OMT
programme. These variations were associated with mea-
surable differences in caseload, intensity of case manage-
ment and patient outcomes. These findings add to the
body of evidence that staff attitudes are associated with
programme policies and the intensity and style of case
management and, subsequently, patient outcomes in opi-
oid maintenance treatment. Policy makers and stakehold-
ers, as well as programme managers and OMT staff need
to be aware of this.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
LG participated in the conception and design of the study, carried out the data
collection, analyzed and interpreted the data and drafted the manuscript. HW
participated in the conception and design of the study, interpreted the data
and revised the manuscript critically for intellectual content. JRMC participated
in the analysis and interpretation of the data and revised the manuscript criti-
cally for intellectual content. MG participated in the analysis and interpretation
of the data and revised the manuscript critically for intellectual content. TC par-
ticipated in the conception and design of the study, participated in the inter-
pretation of the data and revised the manuscript critically for intellectual
content. All authors read and approved the final manuscript.
Acknowledgements
We thank staff employed in the Norwegian OMT program (LAR) for participat-
ing and supporting this study. Also a great thanks to Professor Kenneth Roth-
man who gave invaluable advice on how to analyse and interpret the data. 
This study was funded through the Agency for Alcohol and Drug Addiction 
Services in Oslo, Norway.
Author Details
1SERAF- Norwegian Centre for Addiction Research, Institute of Clinical 
Medicine, University of Oslo, (Kirkeveien 166), Oslo, (0407), Norway, 2Sydney 
School of Public Health, University of Sydney, (Edward Ford Building A27), NSW, 
(2006), Australia and 3Kings College London, National Addiction Centre/
Institute of Psychiatry, (4 Windsor Walk), London (SE5 8AF), UK
References
1. Dole VP, Nyswander ME: Rehabilitation of heroin addicts after blockade 
with methadone.  N Y State J Med 1966, 66:2011-2017.
2. Ball J.C, Ross A: The effectivness of methadone maintenance treatment.  
New York: Springer; 1991. 
3. Clausen T, Anchersen K, Waal H: Mortality prior to, during and after 
opioid maintenance treatment (OMT): a national prospective cross-
registry study.  Drug & Alcohol Dependence 2008, 94:151-157.
4. Joseph H, Stancliff S, Langrod J: Methadone maintenance treatment 
(MMT): a review of historical and clinical issues.  Mt Sinai J Med 2000, 
67:347-364.
5. Jaffe JH, O'Keeffe C: From morphine clinics to buprenorphine: 
Regulating opioid agonist treatment of addiction in the United States.  
Drug Alcohol Depend 2003, 70:S3-S11.
6. Stewart D, Gossop M, Marsden J: Methadone treatment: outcomes and 
variation in treatment response within NTORS.  In Methadone matters 
evolving community methadone treatment of opiate addiction Edited by: 
Strang J, Tober G. London: Martin Dunitz; 2003:249-291. 
7. Ball JC, Ross A: The effectivness of methadone maintenance treatment 1st 
edition. New York: Springer; 1991. 
8. Roe G: Harm reduction as paradigm: Is better than bad good enough? 
The origins of harm reduction.  Critical Public Health 2005, 15:243-250.
9. Gossop M, Marsden J, Stewart D, Treacy S: Outcomes after methadone 
maintenance and methadone reduction treatments: two-year follow-
up results from the National Treatment Outcome Research Study.  Drug 
& Alcohol Dependence 2001, 62:255-264.
10. Gossop M, Grant M: Six country survey of the content and structure of 
heroin treatment programmes using methadone.  Br J Addict 1991, 
86:1151-1160.
11. Stewart D, Gossop M, Marsden J, Strang J: Variation between and within 
drug treatment modalities: data from the National Treatment 
Outcome Research Study (UK).  Eur Addict Res 2000, 6:106-114.
12. D'Aunno T: The role of organization and management in substance 
abuse treatment: Review and roadmap.  J Subst Abuse Treat 2006, 
31:221-233.
13. Grella CE, Greenwell L, Prendergast M, Farabee D, Hall E, Cartier J, et al.: 
Organizational characteristics of drug abuse treatment programs for 
offenders.  J Subst Abuse Treat 2007, 32:291-300.
14. Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, et al.: 
Attitudes and practices regarding the use of methadone in US state 
and federal prisons.  J Urban Health 2005, 82:411-419.
15. Rieckmann T, Daley M, Fuller BE, Thomas CP, McCarty D: Client and 
counselor attitudes toward the use of medications for treatment of 
opioid dependence.  J Subst Abuse Treat 2007, 32:207-215.
16. Cameron IM, Matheson CI, Bond CM, van Teijlingen ER, Wardell FA, 
Cronkshaw G, et al.: A national survey of nurses working in the 
management of illicit drug misuse in Scotland.  International Journal of 
Drug Policy 2006, 17:442-446.
17. Arfken CL, Agius E, Dickson MW, Anderson HL, Hegedus AM: Clinicians' 
Beliefs and Awareness of Substance Abuse Treatments in Research- 
and Nonresearch-Affiliated Programs.  Journal of Drug Issues 2005, 
35:547-558.
18. Andrews S, Sorensen J, Guydish J, Delucchi K, Greenberg B: Knowledge 
and Attitudes About Methadone Maintenance Among Staff Working in 
a Therapeutic Community.  Journal of maintenance in the addictions 
2005, 3:47-59.
19. Albery IP, Heuston J, Ward J, Groves P, Durand MA, Gossop M, et al.: 
Measuring therapeutic attitude among drug workers.  Addict Behav 
2003, 28:995-1005.
20. Caplehorn JR, Lumley TS, Irwig L: Staff attitudes and retention of 
patients in methadone maintenance programs.  Drug Alcohol Depend 
1998, 52:57-61.
21. Caplehorn JR, Irwig L, Saunders JB: Physicians' attitudes and retention of 
patients in their methadone maintenance programs.  Subst Use Misuse 
1996, 31:663-677.
22. Pollack HA, D'Aunno T: Dosage patterns in methadone treatment: 
results from a national survey, 1988-2005.  Health Serv Res 2008, 
43:2143-2163.
23. D'Ippoliti D, Davoli M, Perucci CA, Pasqualini F, Bargagli AMI: Retention in 
treatment of heroin users in Italy: the role of treatment type and of 
methadone maintenance dosage.  Drug Alcohol Depend 1998, 
52:167-171.
24. Caplehorn JR, McNeil DR, Kleinbaum DG: Clinic policy and retention in 
methadone maintenance.  Int J Addict 1993, 28:73-89.
25. Ajzen I: Attitudes, personality, and behavior Maidenhead, Berkshire, 
England: Open University Press; 2005. 
26. Sherif M: The psychology of social norms New York: Octagon Books; 1973. 
27. Asch SE: Studies of Independence and Conformity .1. A Minority of One 
Against A Unanimous Majority.  Psychol Monogr 1956, 70:1-70.
28. Rabinovich A, Morton T, Postmes T: Time perspective and attitude-
behaviour consistency in future-oriented behaviours.  Br J Soc Psychol 
2010:69-89.
29. Bretteville-Jensen AL, Amundsen EJ: Injecting drug use in Norway. 5 Oslo, 
SIRUS; 2006. 
30. Waal H, Clausen T, Håseth A, Lillevold PH: The 2007 annual assessment of 
the Norwegian OMT programme. 1 Oslo Norwegian Centre for Addiction 
Research University of Oslo; 2008. 
31. Waal H: Merits and problems in high-threshold methadone 
maintenance treatment. Evaluation of medication-assisted 
rehabilitation in Norway 1998-2004.  Eur Addict Res 2007, 13:66-73.
Received: 16 December 2009 Accepted: 6 July 2010 
Published: 6 July 2010
This article is available from: http://www.biomedcentral.com/1472-6963/10/194© 2010 Gj r ing et al; licensee BioMed Central Ltd. is an Open Access articl  distributed under h  terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Hea th S r ices R sear h 2010, 10:194
Gjersing et al. BMC Health Services Research 2010, 10:194
http://www.biomedcentral.com/1472-6963/10/194
Page 8 of 832. Waal H, Clausen T, Aamodt C, Lillevold PH: The 2005 annual assessment 
of the Norwegian OMT programme. 1.  Norwegian Centre for Addiction 
Research, University of Oslo; 2006. 
33. Waal H, Clausen T, Aamodt C, Lillevold PH: The 2006 annual assessment 
of the Norwegian OMT programme. 1.  Oslo, Norwegian Centre for 
Addiction Research, University of Oslo; 2007. 
34. Gjersing L, Caplehorn JR, Clausen T: Cross-cultural adaptation of 
research instruments: language, setting, time and statistical 
considerations.  BMC Med Res Methodol 2010, 10:13.
35. Likert R: A technique for the measurement of attitudes.  Archives of 
psychology 1932, 140:5-53.
36. Vånar M: Evaluering av datakvaliteten til "Statusrapportskjemaet" -et 
måleinstrument for pasienter i legemiddelassistert rehabilitering. 1.  
Oslo, Norwegian Centre for Addiction Research, University of Oslo; 2005. 
37. SPSS Inc: SPSS (release 16.0) statistical software.  Chicago, Illinois, SPSS 
Inc; 2008. 
38. Rothman KJ: Epidemiology an introduction Oxford: Oxford University Press; 
2002. 
39. Matheson C, Bond CM, Mollison J: Attitudinal factors associated with 
community pharmacists' involvement in services for drug misusers.  
Addiction 1999, 94:1349-1359.
40. Van DM, Sleegers P, Hutschemaekers G: Professionals' attitudes toward 
reducing restraint: The case of seclusion in The Netherlands.  Psychiatric 
Quarterly 2008, 79:97-109.
41. Stewart D, Gossop M, Marsden J: Increased caseloads in methadone 
treatment programs: Implications for the delivery of services and 
retention in treatment.  J Subst Abuse Treat 2004, 27:301-306.
42. Ghose T: Organizational- and individual-level correlates of 
posttreatment substance use: a multilevel analysis.  J Subst Abuse Treat 
2008, 34:249-262.
43. Moos RH, King MJ, Burnett EB, Andrassy JM: Community residential 
program policies, services, and treatment orientations influence 
patients' participation in treatment.  J Subst Abuse 1997, 9:171-187.
44. Magura S, Nwakeze PC, Kang SY, Demsky S: Program quality effects on 
patient outcomes during methadone maintenance: a study of 17 
clinics.  Subst Use Misuse 1999, 34:1299-1324.
45. McLellan AT, Hagan TA, Levine M, Meyers K, Gould F, Bencivengo M, et al.: 
Does clinical case management improve outpatient addiction 
treatment.  Drug & Alcohol Dependence 1999, 55:91-103.
46. Gar MC, Marina S, Elizabeth KM, Hoffman Robert S, Nelson Lewis S: Testing 
Positive for Methadone and Either a Tricyclic Antidepressant or a 
Benzodiazepine Is Associated with an Accidental Overdose Death: 
Analysis of Medical Examiner Data.  Acad Emerg Med 2006, 13:543-547.
47. Mikolaenko I, Robinson CA Jr, Davis GG: A review of methadone deaths 
in Jefferson County, Alabama.  American Journal of Forensic Medicine & 
Pathology 2002, 23:299-304.
48. Darke S, Swift W, Hall W, Ross M: Drug use, HIV risk-taking and 
psychosocial correlates of benzodiazepine use among methadone 
maintenance clients.  Drug Alcohol Depend 1993, 34:67-70.
49. Clausen T, Waal H, Thoresen M, Gossop M: Mortality among opiate users: 
opioid maintenance therapy, age and causes of death.  Addiction 2009, 
104:1356-1362.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6963/10/194/prepub
doi: 10.1186/1472-6963-10-194
Cite this article as: Gjersing et al., Staff attitudes and the associations with 
treatment organisation, clinical practices and outcomes in opioid mainte-
nance treatment BMC Health Services Research 2010, 10:194
